Literature DB >> 27639069

Human Brain Malignant Glioma (BMG-1) 3D Aggregate Morphology and Screening for Cytotoxicity and Anti-Proliferative Effects.

Maddaly Ravi1, Aarthi Ramesh1, Aishwarya Pattabhi1.   

Abstract

Two interesting aspects of cell lines grown in 3 Dimensional (3D) conditions are their distinct morphology and production of extracellular matrix (ECM). Also, it is known that 3D aggregates have different susceptibilities to damage-inducing agents compared to their 2D monolayer counterparts. We describe the effect of ECM on 3D aggregate morphology, the effect of cisplatin, bleomycin, and UV on the 3D aggregates and 2 Dimensional (2D) monolayers of the BMG-1 cell line. We also present a rapid method for analyzing cytotoxicity and anti-proliferative effects of 3D aggregates in 96-well plates. We utilized a single-step protocol using the dye resazurin. BMG-1 cells formed floating aggregates on 1% agarose hydrogels. The extent of ECM formed by them was dependent on number of cells seeded irrespective of the seeding density, which in turn directed the 3D aggregate compactness. The 3D aggregates were less susceptible to cisplatin and UV-induced cytotoxicity compared to 2D counterparts. The IC50 value of cisplatin was elevated at 210 μg/ml for the aggregates compared to 170 μg/ml for the monolayers. Exposure to UV for 0, 10, 20, and 30 min gave inhibition values of 2.98%, 8%, 22.99%, and 31.8% for the aggregates as compared to 3.06%, 7.5%, 39.4%, and 46.7% for the monolayers. While bleomycin-induced effects were unapparent when analyzed by vital staining for the doses used, the rapid, single-step method in 96-well plates was able to provide a dose-response for cytotoxicity and anti-proliferative effects. Also, comparative analysis of results obtained from vital staining and the single-step method demonstrates the reliability of the assay described. J. Cell. Physiol. 232: 685-690, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27639069     DOI: 10.1002/jcp.25603

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  2 in total

1.  Multiplexed drug testing of tumor slices using a microfluidic platform.

Authors:  A Folch; R C Rostomily; L F Horowitz; A D Rodriguez; Z Dereli-Korkut; R Lin; K Castro; A M Mikheev; R J Monnat
Journal:  NPJ Precis Oncol       Date:  2020-05-19

2.  Multiplexed drug testing of tumor slices using a microfluidic platform.

Authors:  A Folch; R C Rostomily; L F Horowitz; A D Rodriguez; Z Dereli-Korkut; R Lin; K Castro; A M Mikheev; R J Monnat
Journal:  NPJ Precis Oncol       Date:  2020-05-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.